Hasija Amit
CFO & EVP of Corp. Development
Hasija Amit has filed 1 SEC Form 4 filing (4 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Jan 28, 2026.
On the most recent filing, Hasija Amit is listed as CFO & EVP of Corp. Development at Milestone Pharmaceuticals Inc. Inside the rolling window, Hasija Amit reported no open-market purchases and 2 open-market sales totaling $158K in MIST. The largest disclosed transaction in the window is a sale of 58,007 MIST shares on Dec 15, 2025, worth $135K.
Companies traded
Other insiders at MIST
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$158K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Hasija Amit made?
Hasija Amit has filed 1 SEC Form 4 filing (4 transaction rows) across 1 company since 2026.
Which companies does Hasija Amit trade?
Hasija Amit has filed SEC Form 4 disclosures for 1 company, including MIST.
When was Hasija Amit's most recent SEC Form 4 filing?
Hasija Amit's most recent SEC Form 4 filing on Tracefour is dated Jan 28, 2026.
What is Hasija Amit's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Hasija Amit is listed as CFO & EVP of Corp. Development.
What is Hasija Amit's total buy and sell value in the current window?
Inside the rolling retention window, Hasija Amit bought $0 and sold $158K based on SEC Form 4 filings.
What was Hasija Amit's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 58,007 MIST shares on 2025-12-15, worth $135K, per SEC Form 4 filings.